Top Markets
#1 Black Phoenix Black Phoenix +197.93%
#2 Islamic Coin Islamic Coin +157.91%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +50.78%
#5 BasedHype BasedHype +32.69%
#6 Acurast Acurast +23.82%
#7 Cryptopia Cryptopia +21.79%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +19.28%
#9 Akedo Akedo +19.20%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
GENinCode plc GENinCode plc

GENinCode plc

GENI
Classifica tra le azioni #41230
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Prezzo delle azioni
$0.01205037
Capitalizzazione di mercato
$33.70K
Variazione (1 giorno)
-1.60%
Variazione (1 anno)
-40.84%
Paese
GB
Scambia GENinCode plc (GENI)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per GENinCode plc (GENI)
L’azione GENinCode plc (simbolo: GENI) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 13, 2026.
Una quota di GENI acquistata prima di Aug 13, 2026 equivale oggi a 0 quote di GENI.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 8 x34
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 7 x47
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 0 -
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 4 x15
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 0 -
US